Atmospheric Environment p. 421 - 437 (1994)
Update date:2022-09-26
Topics:
Hayman
Jenkin
Murrells
Johnson
HCFC-123 has been proposed as a replacement for some of the fully halogenated chlorofluorocarbons and other chlorinated hydrocarbons, which are being phased out under the Montreal Protocol. This paper reports laboratory studies which were undertaken to determine kinetic and mechanistic parameters of reactions involved in the atmospheric degradation of HCFC-123 and the use of these parameters in a 2D global model of the troposphere to evaluate the yields of products formed in the degradation. The experimental studies have made use of the laser flash photolysis technique with time-resolved ultra-violet absorption spectroscopy for the kinetic measurements and broad-band ultra-violet absorption spectroscopy for product characterization. Rate coefficients have been determined for the self-reaction of CF3CCl2O2 as (3.6 ± 0.5) x 10-12 cm3 mol-1 s-1 and for its reactions with HO2 and NO as (1.9 ± 0.7) x 10-12 cm3 mol-1 s-1 and (1.5-2.0) x 10-11 cm3 mol-1 s-1, respectively, at room temperature. Kinetic data have also been obtained for the reaction of CF3CCl2O2 with C2H5O2 and two channels have been identified; CF3CCl2O2 + C2H5O2 → CF3CCl2O + C2H5O + O2 k = (9 (-5+9) x 10-13 cm3 mol-1 s-1 and CF3CCl2O2 + C2H5O2 → CF3CCl2OH + CH3CHO + O2, k = (3.6 ± 0.5) x 10-12 cm3 mol-1 s-1. Studies undertaken using the Cl-initiated oxidation of HCFC-123 suggest that trifluoroacetyl chloride, CF3COCl, is the major product of the gas-phase degradation. The kinetic and mechanistic data have been used to formulate a chemical module of the degradation of HCFC-123 in the troposphere. The module has been incorporated into a 2D model of the global troposphere so that the potential atmospheric impact of using HCFC-123 can be assessed. HCFC-123 has been proposed as a replacement for some of the fully halogenated chlorofluorocarbons and other chlorinated hydrocarbons, which are being phased out under the Montreal Protocol. This paper reports laboratory studies which were undertaken to determine kinetic and mechanistic parameters of reactions involved in the atmospheric degradation of HCFC-123 and the use of these parameters in a 2D global model of the troposphere to evaluate the yields of products formed in the degradation. The experimental studies have made use of the laser flash photolysis technique with time-resolved ultra-violet absorption spectroscopy for the kinetic measurements and broad-band ultra-violet absorption spectroscopy for product characterization. Rate coefficients have been determined for the self-reaction of CF3CCl2O2 as (3.6±0.5)×10-12 cm3 mol-1 s-1 and for its reactions with HO2 and NO as (1.9±0.7)×10-12 cm3 mol-1 s-1 and (1.5-2.0)×10-11 cm3 mol-1 s-1, respectively, at room temperature. Kinetic data have also been obtained for the reaction of CF3CCl2O2 with C2H5O2 and two channels have been identified; CF3CCl2O2+C2H5O2→CF3CCl$ -2$/O+C2 H5O+O2, k = (9-5+9)×10-13 cm3 mol-1 s-1 and CF3CCl2O2+C2H5O2→CF3CCl$ -2$/OH+CH3 CHO+O2, k = (3.6±0.5)×10-12 cm3 mol-1 s-1. Studies undertaken using the Cl-initiated oxidation of HCFC-123 suggest that trifluoroacetyl chloride, CF3COCl, is the major product of the gas-phase degradation. The kinetic and mechanistic data have been used to formulate a chemical module of the degradation of HCFC-123 in the troposphere. The module has been incorporated into a 2D model of the global troposphere so that the potential atmospheric impact of using HCFC-123 can be assessed.
View MoreHangzhou Ledun Technology Co.,Ltd.
Contact:86-571-18767088918
Address:No.6 street,XiaSha,Hangzhou,China.
Zhuhai Jiacheng Biological Technology Co., Ltd
Contact:0756-8800233
Address:room 222, Lianhua road , Gongbei ,Zhuhai, Guangdong ,China
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
JiYi Chemical (Beijing) Co., Ltd.
Contact:+86-10-89385733
Address:Shilou Town of Fangshan District, Beijing
Contact:+86-18653358619
Address:zibo
Doi:10.1021/j100404a017
(1986)Doi:10.3390/pharmaceutics13040493
(2021)Doi:10.1246/bcsj.52.2223
(1979)Doi:10.1002/adsc.200600575
(2007)Doi:10.1021/ja01101a037
(1953)Doi:10.1021/ja01337a046
(1933)